Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (USD $)	Redeemable Convertible Preferred Stock Series B	Convertible Preferred Stock Series A-1	Convertible Preferred Stock Series C	Convertible Preferred Stock Series D	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Amount at Dec. 31, 2014	$ 1,838,025	$ 4,029,576	$ 966		$ 28,029	$ 24,492,450	$ (24,550,308)	$ 4,000,713
Beginning Balance, Shares at Dec. 31, 2014	1,250,000	1,593,389	96,571		2,802,867
Conversion of Series A-1 into common stock on January 10 and February 25, 2015, Shares		(64,019)			38,456
Conversion of Series A-1 into common stock on January 10 and February 25, 2015, Amount		(162,968)			384	162,584
Conversion of Series C into common stock on January 10, 2015, Shares			(96,571)		120,714
Conversion of Series C into common stock on January 10, 2015, Amount			(966)		1,207	(241)
Conversion of Series B into common stock between March 3 and March 20, 2015, Shares	(106,437)				276,883
Conversion of Series B into common stock between March 3 and March 20, 2015, Amount	(160,380)				2,769	157,611		160,380
Accretion of redemption value for Series A-1 from January 1 to March 25, 2015, Shares
Accretion of redemption value for Series A-1 from January 1 to March 25, 2015, Amount		47,749					(47,749)
Accretion of redemption value for Series B from January 1 to March 25, 2015, Shares
Accretion of redemption value for Series B from January 1 to March 25, 2015, Amount	45,485						(45,485)	(45,485)
Deemed dividend related to exchange of common stock for Series A-1, Series A-1 Warrants and Series B on March 25, 2015, Shares
Deemed dividend related to exchange of common stock for Series A-1, Series A-1 Warrants and Series B on March 25, 2015, Amount	8,655,998	9,196,923					(17,852,921)	(8,655,998)
Exchange of Series A-1, and Series A-1 Warrants into common on and Series D on March 25, 2015, Shares		(1,529,370)		117,583	2,213,407
Exchange of Series A-1, and Series A-1 Warrants into common and Series D on March 25, 2015, Amount		(13,111,280)		1,176	22,134	13,087,970
Exchange of Series B into common and Series D on March 25, 2015, Shares	(1,143,563)			120,573	324,095
Exchange of Series B into common and Series D on March 25, 2015, Amount	(10,379,128)			1,206	3,241	10,374,681		10,379,128
Private Placement Issuance of 6,661,000 shares at $0.75 per share, net of issuance costs of $281,023 on March 31, 2015, Shares					6,661,000
Private Placement Issuance of 6,661,000 shares at $0.75 per share, net of issuance costs of $281,023 on March 31, 2015, Amount					66,610	4,648,116		4,714,726
Issuance of additional common stock in March 2015 under Common Stock Purchase Agreement in relation to Financing on July 7, 2014, Shares					88,093
Issuance of additional common stock in March 2015 under Common Stock Purchase Agreement in relation to Financing on July 7, 2014, Amount					881	(881)
Elimination of warrant liability in exchange transaction						72,656		72,656
Stock-based compensation						82,772		82,772
Net loss							(2,447,320)	(2,447,320)
Ending Balance, Amount at Mar. 31, 2015				$ 2,382	$ 125,255	$ 53,077,718	$ (44,943,783)	$ 8,261,572
Ending Balance, Shares at Mar. 31, 2015				238,156	12,525,515